OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
ORHB
ORHUB, Inc.
Common Stock
Warning! This security is eligible for Unsolicited Quotes Only
This stock is not eligible for proprietary broker-dealer quotations. All quotes in this stock reflect unsolicited customer orders. Unsolicited-Only stocks have a higher risk of wider spreads, increased volatility, and price dislocations. Investors may have difficulty selling this stock. An initial review by a broker-dealer under SEC Rule15c2-11 is required for brokers to publish competing quotes and provide continuous market making.Warning! This security is traded on the Expert Market
The Expert Market® serves broker-dealer pricing and investor best execution needs. Quotations in Expert Market securities are restricted from public viewing. OTC Markets Group may designate securities for quoting on the Expert Market when it is not able to confirm that the company is making current information publicly available under SEC Rule 15c2-11, or when the security is otherwise restricted from public quoting. See additional information about the Expert Market here.N/A
N/A
N/A
N/A
Real-Time Level 2 Quote
Bid
Ask
MPID MPID | Bid Price Bid Price | Size Size | Time Time |
|---|---|---|---|
ETRF | 24.90 | >year | |
CDEL | 21.92 | 03/16 | |
MACM | 18.95 | >year | |
NITE | 18.95 | >year | |
CSTI | 18.55 | >year |
MPID MPID | Ask Price Ask Price | Size Size | Time Time |
|---|---|---|---|
INTL | 19.40 | >year | |
NITE | 19.40 | >year | |
MACM | 19.43 | >year | |
MAXM | 20.11 | >year | |
CANT | 22.05 | >year |
No Real Time Level 2 Quotes Available on Expert Tier
Trade Data
Date Date | Timestamp Timestamp | Price Price | $ Change $ Change | Volume Volume |
|---|---|---|---|---|
| 07/11/2025 | 09:30:19 | 0.0002 | 0.00 | 176 |
| 07/10/2025 | 09:30:19 | 0.0002 | 0.00 | 18,383 |
| 07/03/2025 | 09:33:48 | 0.0002 | 0.00 | 29,820 |
| 07/01/2025 | 14:04:22 | 0.0002 | 0.00 | 35,900 |
| 07/01/2025 | 14:00:49 | 0.0002 | 0.00 | 44,100 |
News
Hippofi Welcomes Scott Bauccio as New Head of Sales for Pur BiologicsAccesswire | 01/23/2024
HIPPOFI WELCOMES SCOTT BAUCCIO AS NEW HEAD OF SALES FOR PUR BIOLOGICSOTC Disclosure & News Service | 01/23/2024
HippoFi Ships International Orders and Expects Sales to Exceed $20 Million in the New YearAccesswire | 12/11/2023
Filings and Disclosure
Company Description
HippoFi is a healthcare innovator and publicly traded company, delivering proprietary technologies in the multi-billion-dollar Spine, Orthopedic, and Cancer markets. The company's purpose is to improve patient care and outcomes by utilizing biotech and AI technologies to address degenerative and diseased conditions affecting the quality of life. HippoFi's business is designed to drive company value by commercializing and monetizing innovative solutions, acquiring assets, and licensing technologies, establishing strategic partnerships and industry alliances, and leveraging its worldwide sales channels. The operations of the company comprise of two segments: Regenerative Therapeutics and Intelligent Automation. PUR Biologics, a wholly owned subsidiary of HippoFi, Inc. (OTCPK: ORHB), is a leading biologic company committed to supporting surgeons and hospitals in providing the best care for their patients. PUR Biologics' full line of biologic products currently include: advanced allografts and demineralized extracellular matrixes (d-ECM), innovative synthetic solutions, cellular derived tissues, and a future of next generation regenerative stem cell and growth factor driven therapeutics for treating osteoarthritis and cartilage regeneration. HippoFi's Regenerative Therapeutics division is actively developing and deploying scalable biological solutions into the $1.37 Trillion (13.96% CAGR) biotechnology market.
Videos
This company has not added any videos
This market serves broker-dealer pricing and investor best execution needs. Quotations in Expert Market securities are restricted from public viewing.
OTC Markets Group is unable to confirm this company is providing public disclosure to a regulator, an exchange, or OTC Markets Group.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.
Loading...
Symbol
OTCM
Last
57.41
Change
0.41 (0.72%)
Bid
57.40
Ask
58.40
Volume
667
Time
00:00
